Mark Endsley

612 total citations
18 papers, 436 citations indexed

About

Mark Endsley is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Mark Endsley has authored 18 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in Mark Endsley's work include Immune Cell Function and Interaction (7 papers), HIV Research and Treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mark Endsley is often cited by papers focused on Immune Cell Function and Interaction (7 papers), HIV Research and Treatment (6 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Mark Endsley collaborates with scholars based in United States, France and Netherlands. Mark Endsley's co-authors include Janice J. Endsley, D. Mark Estes, Monique R. Ferguson, James L. Murray, Guangyu Li, Mark A. McIntosh, David R. Lee, Jason L. Furrer, Alexander C. Maue and W. Ray Waters and has published in prestigious journals such as The Journal of Immunology, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Mark Endsley

15 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Endsley United States 10 162 138 120 83 77 18 436
Nicanor Obaldía Panama 17 257 1.6× 166 1.2× 215 1.8× 70 0.8× 130 1.7× 38 971
Sofia N. Moraes United States 8 64 0.4× 121 0.9× 98 0.8× 31 0.4× 56 0.7× 12 294
Luz Mary Salazar Colombia 18 220 1.4× 52 0.4× 366 3.0× 119 1.4× 87 1.1× 42 671
Franziska Mohring United Kingdom 13 145 0.9× 41 0.3× 171 1.4× 30 0.4× 48 0.6× 20 529
Louis J. Nkrumah United States 8 111 0.7× 51 0.4× 158 1.3× 30 0.4× 65 0.8× 9 521
Adriana Bermúdez Colombia 15 167 1.0× 51 0.4× 311 2.6× 52 0.6× 63 0.8× 36 500
Matthew B. Huante United States 10 109 0.7× 203 1.5× 110 0.9× 38 0.5× 101 1.3× 21 404
Kamalakannan Vijayan United States 10 110 0.7× 107 0.8× 141 1.2× 108 1.3× 69 0.9× 26 426
Wouter Graumans Netherlands 16 379 2.3× 118 0.9× 135 1.1× 34 0.4× 60 0.8× 36 911

Countries citing papers authored by Mark Endsley

Since Specialization
Citations

This map shows the geographic impact of Mark Endsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Endsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Endsley more than expected).

Fields of papers citing papers by Mark Endsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Endsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Endsley. The network helps show where Mark Endsley may publish in the future.

Co-authorship network of co-authors of Mark Endsley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Endsley. A scholar is included among the top collaborators of Mark Endsley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Endsley. Mark Endsley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Shelite, Thomas R., Tseng Hsiang-Chi, Matthew B. Huante, et al.. (2025). IL-4 and TGF-β regulate inflammatory cytokines and cellular infiltration in the lung and systemic IL-6 in mouse-adapted SARS-CoV-2 infection. ImmunoHorizons. 9(9).
2.
3.
Chauhan, Sadhana, Rebecca J. Nusbaum, Matthew B. Huante, et al.. (2024). Therapeutic Modulation of Arginase with nor-NOHA Alters Immune Responses in Experimental Mouse Models of Pulmonary Tuberculosis including in the Setting of Human Immunodeficiency Virus (HIV) Co-Infection. Tropical Medicine and Infectious Disease. 9(6). 129–129. 2 indexed citations
5.
Hage, Adam, Hongjie Xia, Matthew B. Huante, et al.. (2022). The E3-ligase TRIM7 acts as an antiviral factor by ubiquitinating the SARS-CoV-2 membrane protein to limit apoptosis and virus replication. The Journal of Immunology. 208(Supplement_1). 51.07–51.07. 1 indexed citations
6.
Files, Megan, et al.. (2022). Differential regulation of macrophage galactose-type lectin (MGL) orthologs by mycobacterial ligands. The Journal of Immunology. 208(Supplement_1). 51.09–51.09. 1 indexed citations
7.
Bharaj, Preeti, Joshua G. Lisinicchia, Sadhana Chauhan, et al.. (2022). Defects in macrophage galactose-type lectin (MGL) signaling and pathogenesis of Mycobacterium tuberculosis and Human Immunodeficiency virus co-infection. The Journal of Immunology. 208(Supplement_1). 50.29–50.29. 1 indexed citations
8.
Endsley, Janice J., et al.. (2021). Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse. Retrovirology. 18(1). 14–14. 6 indexed citations
9.
Huff, Sarah, Indrasena Reddy Kummetha, Shashi Kant Tiwari, et al.. (2021). Discovery and Mechanism of SARS-CoV-2 Main Protease Inhibitors. Journal of Medicinal Chemistry. 65(4). 2866–2879. 79 indexed citations
10.
Huante, Matthew B., Taís B. Saito, Rebecca J. Nusbaum, et al.. (2020). Small Animal Model of Post-chemotherapy Tuberculosis Relapse in the Setting of HIV Co-infection. Frontiers in Cellular and Infection Microbiology. 10. 150–150. 11 indexed citations
11.
Akil, Abdellah, Mark Endsley, Ómar A. Saldarriaga, et al.. (2019). Fibrogenic Gene Expression in Hepatic Stellate Cells Induced by HCV and HIV Replication in a Three Cell Co-Culture Model System. Scientific Reports. 9(1). 568–568. 18 indexed citations
12.
Xu, Jimin, Megan Files, Jeffrey D. Cirillo, et al.. (2019). Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing). Tuberculosis. 116. S28–S33. 26 indexed citations
13.
Endsley, Mark, Anoma Somasunderam, Guangyu Li, et al.. (2014). Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domain. Virology. 454-455. 60–66. 14 indexed citations
14.
Li, Guangyu, et al.. (2014). The dual role of tetraspanin CD63 in HIV-1 replication. Virology Journal. 11(1). 23–23. 34 indexed citations
15.
Friedrich, Brian, Natallia Dziuba, Guangyu Li, et al.. (2011). Host factors mediating HIV-1 replication. Virus Research. 161(2). 101–114. 68 indexed citations
16.
Endsley, Mark, Leo M. Njongmeta, Matthew W. Ryan, et al.. (2009). Human IgA-Inducing Protein from Dendritic Cells Induces IgA Production by Naive IgD+ B Cells. The Journal of Immunology. 182(4). 1854–1859. 23 indexed citations
17.
Endsley, Janice J., Mark Endsley, & D. Mark Estes. (2005). Bovine natural killer cells acquire cytotoxic/effector activity following activation with IL-12/15 and reduce Mycobacterium bovis BCG in infected macrophages. Journal of Leukocyte Biology. 79(1). 71–79. 51 indexed citations
18.
Endsley, Janice J., Jason L. Furrer, Mark Endsley, et al.. (2004). Characterization of Bovine Homologues of Granulysin and NK-lysin. The Journal of Immunology. 173(4). 2607–2614. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026